Draftfcb Healthcare London appoints industry veterans
October 22, 2010Medical Communications Draftfcb, Draftfcb Healthcare, Jeff Daniels, Peter Hudspeth, medical communications
Draftfcb London has appointed Jeff Daniels and Peter Hudspeth as joint managing directors of its healthcare arm. “I’m excited to …
GSK cleared of unethical practices by PMCPA
October 22, 2010Medical Communications ABPI, ABPI Code of Practice, Avamys, GSK, GlaxoSmithKline, PMCPA, Rupafin, Seretide
GlaxoSmithKline has been found guilty of two transgressions of the ABPI Code of Practice in a case centring on the …
M:Communications hires Amber Bielecka
October 22, 2010Medical Communications Amber Bielecka, M:Communications, appointment, medical communications
Financial communications agency M:Communications has appointed Amber Bielecka to its international healthcare practice. She joins the agency from Citigate Dewe …
Revenue slump for GSK as Avandia sales stall
October 22, 2010Sales and Marketing Avandia, GSK, GlaxoSmithKline, UK science budget, patent box, pharma's 2010 results, pharma's Q3 results
GlaxoSmithKline has posted a third quarter loss after sales of its troubled diabetes drug Avandia and pandemic influenza products fell. …
Pfizer recalls Lipitor tablets because of ‘musty’ smell
October 22, 2010Manufacturing and Production Lipitor, Pfizer, pharma recalls, product recalls
Pfizer has recalled 191,000 bottles of its cholesterol drug Lipitor in the US after customers complained of an unusual, musty …
Lilly suspends late-stage trials of diabetes drug Protege
October 22, 2010Research and Development, Sales and Marketing MacroGenics, Protege, diabetes, lilly, type I diabetes
Eli Lilly and its partner MacroGenics have suspended phase III trials of their investigational type I diabetes drug Protege after …
Anna Protopapas to lead Takeda’s global business development unit
October 21, 2010Sales and Marketing Anna Protopapas, Japanese pharma company, Takeda, appointment, sales and marketing
Takeda has set up a new global business development unit within its US subsidiary to oversee mergers, acquisitions and other …
NHS budget ‘will have to stretch further’
October 21, 2010George Osborne, NHS, NHS Confederation, NHS funding, government, king's fund
The NHS budget has been protected from the worst of the Comprehensive Spending Review’s swingeing cuts, with a raise that …
Johnson & Johnson recalls more Tylenol
October 21, 2010Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, Tylenol, pharma recalls, product recalls
Johnson & Johnson’s McNeil Consumer Healthcare unit has announced yet another recall affecting its Tylenol painkiller range. The latest recall …
Pfizer extends portfolio with Brazilian generics deal
October 21, 2010Brazil, IMS Health, Pfizer, em, emerging pharma marketings
Pfizer is partnering with leading Brazilian generics firm Laboratorio Teuto Brasileiro to develop and commercialise a number of generic products …
Novartis posts strong Q3 results
October 21, 2010Sales and Marketing 2010 financials, Novartis, Novartis quarterly results, Q3, pharma sales
Novartis has posted double digit growth for the third quarter following a strong showing by a number of recently launched …
Staff blockade Sanofi-Aventis facility in France
October 21, 2010Manufacturing and Production France, Sanofi, Sanofi-Aventis, job cuts, manufacturing and production
Workers at a Sanofi-Aventis manufacturing facility in Romainville, France, sealed off the gates of the plant to protest plans to …
European medicines legislation and pharmacovigilance
October 20, 2010Research and Development NDA, pharmacovigilance, regulatory affairs
During the past decade, changes in European medicines legislation and guidelines have increased the scope and regulatory scrutiny of pharmacovigilance …
UK science in line for £500m boost from EU
October 20, 2010Research and Development UK Biobank, UKCMRI, biotech funding, life sciences, science parks
The European Investment Bank has unveiled a £500 million package of loans to boost the UK’s science and education base …
FDA approves Boehringer’s Pradaxa
October 20, 2010Sales and Marketing Boehringer, Pradaxa, atrial fibrilation
Boehringer Ingelheim’s Pradaxa has stolen a march over its rivals by being the first new oral anticoagulant to reach the …
FDA warns of bisphosphonates fracture risk
October 20, 2010Sales and Marketing Boniva, Fosamax, Reclast, actonel, bisphosphonates, osteoporosis
The FDA has ordered a label change for a number of osteoporosis drugs after concerns their long-term use raises the …
NICE needs narrower focus, says ABPI
October 20, 2010Sales and Marketing ABPI, NICE, value
NICE’s remit should be changed to give it a greater focus on the value of innovation, according to UK pharma …
King’s Fund appoints Kaye Lobley to leadership post
October 20, 2010UK, appointment, king's fund
Kate Lobley will take up the post of director of leadership at health think tank The King’s Fund on 1 …
Apixaban trial for ACS abandoned
October 20, 2010Sales and Marketing ACS, BMS, Pfizer, apixaban
Pfizer and Bristol-Myers Squibb have halted a trial of their heart drug apixaban after signs of increased risk of …
Digital Pharma: NHS to lead an ‘information revolution’
October 19, 2010Medical Communications Digital Pharma blog, electronic patient records, patient information
Patients could soon be able to contact their doctor online as part of government plans for an ‘information revolution’ in …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
